Skip to main content
Top
Published in: Journal of Neurology 12/2012

01-12-2012 | Original Communication

Vitamin D levels in Hispanics with multiple sclerosis

Authors: Lilyana Amezcua, Rachel H. Chung, David V. Conti, Annette M. Langer-Gould

Published in: Journal of Neurology | Issue 12/2012

Login to get access

Abstract

Vitamin D has been associated with multiple sclerosis (MS) and several markers of disease state in whites. There are limited reports of vitamin D’s influence in MS in ethnic groups, such as in Hispanics. In this study, we compared vitamin D levels in Hispanics and whites with MS and tried to determine whether season or increasing disability influence hypovitaminosis D in Hispanics with MS. Serum 25-hydroxyvitamin D [25(OH)D] levels and clinical characteristics were compared in a cross-sectional sample of Hispanics (n = 80) and whites (n = 80) with MS recruited from the University of Southern California. Serum 25(OH)D levels were significantly lower in Hispanics than whites with MS (mean and standard deviation 25.1 ± 9.4 and 37.3 ± 19.8 ng/ml, respectively; p < 0.001). Hispanics were significantly more likely than whites to be vitamin D insufficient (≤30 ng/ml; 70 vs. 41 %, respectively; p < 0.001) and deficient (≤20 ng/ml; 40 vs. 14 %, respectively, p < 0.001). In Hispanics, serum 25(OH)D levels were not influenced by season (p = 0.8) or higher physical disability (EDSS ≥6, p = 0.7). We found that the relationship between vitamin D and MS differs by Hispanic ethnicity. Hypovitaminosis D was significantly more common among Hispanics than among whites with MS, and the majority of Hispanics were vitamin D insufficient. Interestingly, there was no association between vitamin D levels and season or increasing disability in the Hispanics. Our findings imply that factors influencing vitamin D levels and possibly vitamin D requirements may vary by ethnicity in patients with MS. These results should be confirmed in larger, prospective multi-ethnic cohort studies.
Literature
1.
go back to reference van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T et al (2007) Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 254(5):581–590PubMedCrossRef van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T et al (2007) Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 254(5):581–590PubMedCrossRef
2.
go back to reference Soilu-Hanninen M, Airas L, Mononen I, Heikkila A, Viljanen M, Hanninen A (2005) 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 11(3):266–271 Soilu-Hanninen M, Airas L, Mononen I, Heikkila A, Viljanen M, Hanninen A (2005) 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 11(3):266–271
3.
go back to reference Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R (2008) Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 14(9):1220–1224 Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R (2008) Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 14(9):1220–1224
4.
go back to reference Munger KL, Zhang SM, O’Reilly E, Hernan MA, Olek MJ, Willett WC et al (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62(1):60–65PubMedCrossRef Munger KL, Zhang SM, O’Reilly E, Hernan MA, Olek MJ, Willett WC et al (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62(1):60–65PubMedCrossRef
5.
go back to reference Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296(23):2832–2838PubMedCrossRef Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296(23):2832–2838PubMedCrossRef
6.
go back to reference Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H et al (2010) Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 68(2):193–203PubMed Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H et al (2010) Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 68(2):193–203PubMed
7.
go back to reference Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL et al (2010) Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 67(5):618–624PubMed Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL et al (2010) Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 67(5):618–624PubMed
8.
go back to reference Handel AE, Disanto G, Jarvis L, McLaughlin R, Fries A, Ebers GC et al (2011) Seasonality of admissions with multiple sclerosis in Scotland. Eur J Neurol 18(8):1109–1111PubMedCrossRef Handel AE, Disanto G, Jarvis L, McLaughlin R, Fries A, Ebers GC et al (2011) Seasonality of admissions with multiple sclerosis in Scotland. Eur J Neurol 18(8):1109–1111PubMedCrossRef
9.
go back to reference Gelfand JM, Cree BA, McElroy J, Oksenberg J, Green R, Mowry EM et al (2011) Vitamin D in African Americans with multiple sclerosis. Neurology 76(21):1824–1830PubMedCrossRef Gelfand JM, Cree BA, McElroy J, Oksenberg J, Green R, Mowry EM et al (2011) Vitamin D in African Americans with multiple sclerosis. Neurology 76(21):1824–1830PubMedCrossRef
11.
go back to reference Zadshir A, Tareen N, Pan D, Norris K, Martins D (2005) The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis. Autumn;15(4 Suppl 5):S5-97-101 Zadshir A, Tareen N, Pan D, Norris K, Martins D (2005) The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis. Autumn;15(4 Suppl 5):S5-97-101
12.
go back to reference Moore CE, Murphy MM, Holick MF (2005) Vitamin D intakes by children and adults in the United States differ among ethnic groups. J Nutr 135(10):2478–2485PubMed Moore CE, Murphy MM, Holick MF (2005) Vitamin D intakes by children and adults in the United States differ among ethnic groups. J Nutr 135(10):2478–2485PubMed
13.
go back to reference Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML (2009) Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001–2004. Pediatrics 124(3):e362–e370PubMedCrossRef Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML (2009) Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001–2004. Pediatrics 124(3):e362–e370PubMedCrossRef
14.
go back to reference Amezcua L, Lund B, Weiner L, Islam T (2011) Multiple sclerosis in Hispanics: a study of clinical disease expression. Mult Scler 17(8):1010–1016 Amezcua L, Lund B, Weiner L, Islam T (2011) Multiple sclerosis in Hispanics: a study of clinical disease expression. Mult Scler 17(8):1010–1016
15.
go back to reference Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58(6):840–846PubMedCrossRef Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58(6):840–846PubMedCrossRef
16.
go back to reference Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452PubMedCrossRef Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452PubMedCrossRef
17.
go back to reference Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M et al (2009) Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 94(9):3306–3313PubMedCrossRef Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M et al (2009) Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 94(9):3306–3313PubMedCrossRef
18.
go back to reference Diaz VA, Mainous AG 3rd, Carek PJ, Wessell AM, Everett CJ (2009) The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications for health disparities. J Am Board Fam Med 22(5):521–527PubMedCrossRef Diaz VA, Mainous AG 3rd, Carek PJ, Wessell AM, Everett CJ (2009) The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications for health disparities. J Am Board Fam Med 22(5):521–527PubMedCrossRef
19.
go back to reference Broder AR, Tobin JN, Putterman C (2010) Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and non-autoimmune chronic diseases: a retrospective comparison of three chronic diseases. Arthritis Res Ther 12(5):R191–R220PubMedCrossRef Broder AR, Tobin JN, Putterman C (2010) Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and non-autoimmune chronic diseases: a retrospective comparison of three chronic diseases. Arthritis Res Ther 12(5):R191–R220PubMedCrossRef
22.
go back to reference Engelman CD, Meyers KJ, Ziegler JT, Taylor KD, Palmer ND, Haffner SM et al (2010) Genome-wide association study of vitamin D concentrations in Hispanic Americans: the IRAS family study. J Steroid Biochem Mol Biol 122(4):186–192PubMedCrossRef Engelman CD, Meyers KJ, Ziegler JT, Taylor KD, Palmer ND, Haffner SM et al (2010) Genome-wide association study of vitamin D concentrations in Hispanic Americans: the IRAS family study. J Steroid Biochem Mol Biol 122(4):186–192PubMedCrossRef
23.
go back to reference Simon KC, Munger KL, Kraft P, Hunter DJ, De Jager PL, Ascherio A (2011) Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis. J Neurol 9:1676–1682CrossRef Simon KC, Munger KL, Kraft P, Hunter DJ, De Jager PL, Ascherio A (2011) Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis. J Neurol 9:1676–1682CrossRef
24.
go back to reference Handunnetthi L, Ramagopalan SV, Ebers GC (2010) Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology 74:1905–1910PubMedCrossRef Handunnetthi L, Ramagopalan SV, Ebers GC (2010) Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology 74:1905–1910PubMedCrossRef
25.
go back to reference Renzaho AM, Halliday JA, Nowson C (2010) Vitamin D, obesity, and obesity-related chronic disease among ethnic minorities: a systematic review. Nutrition 27(9):868–879 Renzaho AM, Halliday JA, Nowson C (2010) Vitamin D, obesity, and obesity-related chronic disease among ethnic minorities: a systematic review. Nutrition 27(9):868–879
Metadata
Title
Vitamin D levels in Hispanics with multiple sclerosis
Authors
Lilyana Amezcua
Rachel H. Chung
David V. Conti
Annette M. Langer-Gould
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 12/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6537-z

Other articles of this Issue 12/2012

Journal of Neurology 12/2012 Go to the issue

Pioneers in Neurology

Jorjani (1042–1137)